Feasibility Assessment of Adapted Physical Activity in Patients Treated for a Brain Tumor

NCT07570485 · tracked via the Priya Life Science France tracker

Sponsor

Center Eugene Marquis

Phase

Not applicable

Started

2026-06-01

Last updated

2026-06-12

Condition(s) studied

Brain Tumor Adult

Investigational drug(s) / intervention(s)

adapted physical activity

adapted physical activity: Adapted Physical Activity (APA) is a tailored exercise program designed for individuals with specific health conditions, such as brain tumors. It aims to improve physical function, quality of life, and overall well-being while ensuring safety and feasibility. APA is supervised by trained professionals and adapted to each individual's abilities and needs.

Study summary

The goal of this clinical trial is to assess the feasibility of an adapted physical activity (APA) program in adult patients (≥18 years) with primary brain tumors, regardless of tumor type, grade, treatment stage, or the presence of motor, sensory, attention, concentration, or memory deficits.

The main question it aims to answer is:

What is the effective adherence rate to an APA program among eligible patients with primary brain tumors?

Additional questions include:

* What is the observance rate (number of sessions completed, intensity achieved, and duration) during the 3-month supervised APA program?
* What is the retention rate (proportion of patients completing the program and continuing APA beyond the initial period)?
* What is the impact of APA on quality of life, anxiety-depression, and cancer-related symptoms (measured via QLQ-BN20, HADS, and MFI-20 questionnaires at baseline, 3, and 4 months)?

Participants will:

* Undergo a 3-month supervised APA program (with possible continuation beyond this period).
* Use connected watches to monitor physical activity (if they accept the general conditions of use).
* Complete self-questionnaires (IPAQ, BREQ-2, QPP, QLQ-BN20, HADS, MFI-20) at inclusion, 3 months, and 4 months.
* Be followed for a total of 4 months after inclusion.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Men or women ≥ 18 years old, * Receiving medical oncology treatment at the CLCC Eugène Marquis, * Diagnosed with a primary brain tumour, regardless of diagnosis, grade or treatment, * Possible motor, sensory, attention, concentration, or memory deficits, * Patients who accept the general terms of use for connected watches * Patients affiliated with or covered by the French social security system, * Patients who have received information and signed informed consent (or their legal representative), Exclusion Criteria: * WHO score ≥ 3 * Comprehension disorders that prevent participation in adapted physical activity * Pregnant or breastfeeding women * Patients without the necessary devices to use a smartwatch (smartphone, tablet or computer), * Patients deprived of liberty, under guardianship, or curatorship, or subject to any other administrative safeguard measure. Patients unable to comply with the study schedule for social, medical, or psychological reasons.

Primary outcome measure(s)

Effective adherence rate to the Adapted Physical Activity program — Baseline to 4 months
The primary outcome is the proportion of eligible patients who participate in at least one Adapted Physical Activity session out of the total number of eligible patients solicited for inclusion. This metric Evaluates the feasibility of Adapted Physical Activity implementation in brain tumor patients.

Trial sites (1)

Facility	City	Region	Status
Centre Eugène Marquis	Rennes	France

More Center Eugene Marquis trials in France

Evaluation of SIRT Followed by Immunotherapy for Treatment of Hepatocellular Carcinoma With Portal Vein Thrombosis Recruiting

Microbiota Modification for Immuno-oncology in Hepatocellular Carcinoma Recruiting

Phase III Adaptive Adaptive Stereostactic Body Radiotherapy (SBRT) With Dose Escalation for High-Risk Prostate Cancer Recruiting

Systematic Intervention to Improve Sexual Dysfunction Active, not recruiting

Identification of Risk Factors for Brain Recurrence in Patients With HER2-positive Localised Breast Cancer Recruiting

Other trials for the same condition

Picture Naming Decoding From Intraoperative Recordings Starting soon

The Impact of Paramedic Training in Simulation on the Experience of Patients Treated for Malignant Brain Tumors in Neurosurgery (IPSIMANON) Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07570485 on ClinicalTrials.gov ↗ ← All trials in France